UnknownNot Applicable

Interference Screw Mectascrew-C Postmarket Study

Switzerland44 participantsStarted 2023-03-22

Plain-language summary

An observational prospective study with the aim to analyze the presence at 6 months of a specific composite IS (Medacta Mectascrew C) in the reconstructive treatment of ruptured ACL or PCL by means of an autograft or allograft.

Who can participate

Age range16 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of both sexes aged 16-60 yrs * Pre-operative MRI confirming the ACL or PCL rupture * Scheduled for surgical reconstruction of ACL or PCL * BMI\>18 and \<35 kg/m2 * Ability to give informed consent by signature Exclusion Criteria: * Age under 16 or over 60 yrs * Degenerative osteopathies * Local bone tumors * Deformities of the bone, or general conditions of the bone, which preclude the implantation in the opinion of a physician * Systemic diseases and metabolic disorders that may compromise the outcome of the surgery

What they're measuring

Interference screw presence

Timeframe: 6 months

Trial details

NCT IDNCT05791656

SponsorMedacta International SA

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-03

Contact for this trial

Elisa Bonacina, PhD

+41 91 696 60 60 bonacina@medacta.ch

View on ClinicalTrials.gov More Anterior Cruciate Ligament Injuries trials